New diabetes clinical trial: Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults
Published on: July 14, 2024 at 11:00PM
Conditions: Overweight and Obesity
Interventions: Drug: HDM1002 100 mg QD; Drug: HDM1002 200 mg QD 12weeks; Drug: HDM1002 400 mg QD 12weeks; Drug: Placebo
Sponsors: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Not yet recruiting
https://ift.tt/0TACcNf
Conditions: Overweight and Obesity
Interventions: Drug: HDM1002 100 mg QD; Drug: HDM1002 200 mg QD 12weeks; Drug: HDM1002 400 mg QD 12weeks; Drug: Placebo
Sponsors: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Not yet recruiting
https://ift.tt/0TACcNf
Comments
Post a Comment